Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats

P. Foa, F. Chillemi, L. Lombardi, S. Lonati, A. T. Maiolo, E. E. Polli

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The synthetic pentapeptide pGlu-Glu-Asp-Cys-Lys has recently been proposed as the active component of a granulocyte-derived inhibitor of normal haematopoiesis. We investigated its biological activity on leukaemic myelopoiesis both in vitro and in vivo in rats. Three different human permanent myeloid leukaemic cell lines (HL60, KG1 ML3) and a rat transplantable acute myeloid leukaemia (Shay leukaemia) were studied. Neither HL60 nor KG1 were sensitive to the peptide whereas a consistently reproducible inhibition of 3H-TdR uptake was observed in ML3 cells. This effect was not due to an unspecific toxic action on target cells and was spontaneously reversible. When injected i.p. twice daily at an appropriate concentration in rats bearing Shay leukaemia, the peptide caused a significant increase in survival. Our results therefore indicate that the synthetic pentapeptide studied inhibits not only normal but also leukaemic myelopoiesis.

Original languageEnglish
Pages (from-to)399-403
Number of pages5
JournalEuropean Journal of Haematology
Volume39
Issue number5
Publication statusPublished - 1987

Fingerprint

Myelopoiesis
Leukemia
Toxic Actions
Peptides
Hematopoiesis
Myeloid Cells
Granulocytes
Acute Myeloid Leukemia
Cell Line
Survival
In Vitro Techniques

ASJC Scopus subject areas

  • Hematology

Cite this

Foa, P., Chillemi, F., Lombardi, L., Lonati, S., Maiolo, A. T., & Polli, E. E. (1987). Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats. European Journal of Haematology, 39(5), 399-403.

Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats. / Foa, P.; Chillemi, F.; Lombardi, L.; Lonati, S.; Maiolo, A. T.; Polli, E. E.

In: European Journal of Haematology, Vol. 39, No. 5, 1987, p. 399-403.

Research output: Contribution to journalArticle

Foa, P, Chillemi, F, Lombardi, L, Lonati, S, Maiolo, AT & Polli, EE 1987, 'Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats', European Journal of Haematology, vol. 39, no. 5, pp. 399-403.
Foa, P. ; Chillemi, F. ; Lombardi, L. ; Lonati, S. ; Maiolo, A. T. ; Polli, E. E. / Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats. In: European Journal of Haematology. 1987 ; Vol. 39, No. 5. pp. 399-403.
@article{da262d0297514d87a53299118b0b4bfe,
title = "Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats",
abstract = "The synthetic pentapeptide pGlu-Glu-Asp-Cys-Lys has recently been proposed as the active component of a granulocyte-derived inhibitor of normal haematopoiesis. We investigated its biological activity on leukaemic myelopoiesis both in vitro and in vivo in rats. Three different human permanent myeloid leukaemic cell lines (HL60, KG1 ML3) and a rat transplantable acute myeloid leukaemia (Shay leukaemia) were studied. Neither HL60 nor KG1 were sensitive to the peptide whereas a consistently reproducible inhibition of 3H-TdR uptake was observed in ML3 cells. This effect was not due to an unspecific toxic action on target cells and was spontaneously reversible. When injected i.p. twice daily at an appropriate concentration in rats bearing Shay leukaemia, the peptide caused a significant increase in survival. Our results therefore indicate that the synthetic pentapeptide studied inhibits not only normal but also leukaemic myelopoiesis.",
author = "P. Foa and F. Chillemi and L. Lombardi and S. Lonati and Maiolo, {A. T.} and Polli, {E. E.}",
year = "1987",
language = "English",
volume = "39",
pages = "399--403",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "5",

}

TY - JOUR

T1 - Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in rats

AU - Foa, P.

AU - Chillemi, F.

AU - Lombardi, L.

AU - Lonati, S.

AU - Maiolo, A. T.

AU - Polli, E. E.

PY - 1987

Y1 - 1987

N2 - The synthetic pentapeptide pGlu-Glu-Asp-Cys-Lys has recently been proposed as the active component of a granulocyte-derived inhibitor of normal haematopoiesis. We investigated its biological activity on leukaemic myelopoiesis both in vitro and in vivo in rats. Three different human permanent myeloid leukaemic cell lines (HL60, KG1 ML3) and a rat transplantable acute myeloid leukaemia (Shay leukaemia) were studied. Neither HL60 nor KG1 were sensitive to the peptide whereas a consistently reproducible inhibition of 3H-TdR uptake was observed in ML3 cells. This effect was not due to an unspecific toxic action on target cells and was spontaneously reversible. When injected i.p. twice daily at an appropriate concentration in rats bearing Shay leukaemia, the peptide caused a significant increase in survival. Our results therefore indicate that the synthetic pentapeptide studied inhibits not only normal but also leukaemic myelopoiesis.

AB - The synthetic pentapeptide pGlu-Glu-Asp-Cys-Lys has recently been proposed as the active component of a granulocyte-derived inhibitor of normal haematopoiesis. We investigated its biological activity on leukaemic myelopoiesis both in vitro and in vivo in rats. Three different human permanent myeloid leukaemic cell lines (HL60, KG1 ML3) and a rat transplantable acute myeloid leukaemia (Shay leukaemia) were studied. Neither HL60 nor KG1 were sensitive to the peptide whereas a consistently reproducible inhibition of 3H-TdR uptake was observed in ML3 cells. This effect was not due to an unspecific toxic action on target cells and was spontaneously reversible. When injected i.p. twice daily at an appropriate concentration in rats bearing Shay leukaemia, the peptide caused a significant increase in survival. Our results therefore indicate that the synthetic pentapeptide studied inhibits not only normal but also leukaemic myelopoiesis.

UR - http://www.scopus.com/inward/record.url?scp=0023508424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023508424&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 399

EP - 403

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 5

ER -